At some point, probably when Elite shows positive results on their reformulation in a larger study, Elite will garner some real attention from big pharma with the intent of buying the 2 bead technology or what ever worked best. Lets not forget that "big" pharma has an aversion to buying anything that isnt proven even if they pay more for it later. Of course there are those exceptions where well endowed companies jump too soon but the rule seems to be the former. Prior to their little pilot study there was no hope at all, since then I have regained some optimism that someone will show interest in Elite.